{"nct_id":"NCT02216409","title":"Phase 1 Trial of Hu5F9-G4, a CD47-targeting Antibody","status":"COMPLETED","status_verified_date":"2019-02","start_date":"2014-08","start_date_type":"ACTUAL","primary_completion_date":"2018-10","primary_completion_date_type":"ACTUAL","completion_date":"2018-12","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GILD"]}